Total raised
—
Stage
Pre-Funding
Founded
2016
Headcount
2
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
NTB Pharma seeks to develop novel targets for immuno-oncology and cancer immunotherapy utilizing the SLAM family receptors. NTB Pharma hypothesizes that SLAMF6, a highly potent agonistic receptor on immune cells, is a natural candidate for anti-melanoma immunotherapy. Its uniqueness may lie in a dual action on lymphocytes and myeloid-derived suppressor cells, augmenting T-cell function and reversing the deleterious effect of the tumor environment. NTB Pharma was established based on a technology developed in the laboratory of Prof. Lotem at Hadassah Medical Center, Jerusalem.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary focus of NTB Pharma's research and development?
- NTB Pharma focuses on developing novel targets for immuno-oncology and cancer immunotherapy, specifically utilizing the SLAM family receptors.
- What is NTB Pharma's hypothesis regarding SLAMF6?
- NTB Pharma hypothesizes that SLAMF6, an agonistic receptor on immune cells, is a natural candidate for anti-melanoma immunotherapy due to its potential dual action on lymphocytes and myeloid-derived suppressor cells.
- When was NTB Pharma founded?
- NTB Pharma was founded in January 2016.
- What is the current operational status of NTB Pharma?
- NTB Pharma has been inactive since September 2017.
- Where is NTB Pharma headquartered?
- NTB Pharma is headquartered in Jerusalem, Israel, at 8 Sderot Churchill.
- What is the current employee count for NTB Pharma?
- NTB Pharma has 2 employees.
- What is NTB Pharma's current funding stage?
- NTB Pharma is currently in the Pre-Funding stage.
- What is the origin of the technology NTB Pharma is based on?
- NTB Pharma was established based on technology developed in the laboratory of Prof. Lotem at Hadassah Medical Center, Jerusalem.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
biotechnologydiagnosticsregenerative-medicinemedical-technologiescancercancer-therapycell-therapy